Performance Measures:

Practices/hospitals participating in the registry will receive performance calculations for all ImageGuide performance measures. Performance will be provided at the practice/hospital level, office location level, and for each individual participating physician.

CMS Merit-Based Incentive Payment System (MIPS):

In 2018 and 2019, physicians are required to report at least six measures for 60% of the imaging studies. Of the six measures, at least one must be an outcome or high priority measure. IMPORTANT: Performance rates of 0% for normal measures and 100% for inverse measures will not count towards the six measure minimum.

 

2019 ImageGuide Performance Measures

Quality # or QCDR Measure ID Measure Title Measure Type
322 Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients High Priority, Efficiency and Cost/Resource Use
323 Cardiac Stress Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI) High Priority, Efficiency and Cost/Resource Use
324 Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients High Priority, Efficiency and Cost/Resource Use
ASNC19 Imaging Protocols for SPECT and PET MPI studies - Use of stress only protocol High Priority, Outcome
ASNC23 SPECT-MPI study clinical utilization of Attenuation Correction image acquisition High Priority, Process
ASNC28 SPECT-MPI effective dose less than or equal to 9 millisieverts as per ASNC guideline recommendations High Priority, Outcome
ASNC29 SPECT and PET MPI study documentation of stress perfusion defects High Priority, Process
ASNC30 Transthoracic Echo (TTE) studies meeting appropriate use criteria High Priority, Efficiency and Cost/Resource Use
IGR1 Comprehensive TTE studies reporting a measured value of LVEF AND wall motion High Priority, Efficiency and Cost/Resource Use
IGR2 Parameters in dobutamine testing for low flow, low gradient aortic stenosis Not High Priority, Process
IGR3 Myocardial Perfusion Imaging (MPI) or Stress Echocardiography studies meeting appropriate use criteria High Priority, Efficiency and Cost/Resource Use
IGR4 Myocardial Perfusion Imaging (MPI) studies or Stress Echocardiography imaging studies not Equivocal High Priority, Efficiency and Cost/Resource Use
IGR5 Myocardial Perfusion Imaging (MPI) studies, Transthoracic Echo (TTE), or Stress Echocardiography imaging studies reporting Left Ventricular Ejection Fraction  Not High Priority, Process
IGR6 SPECT-MPI or Stress Echocardiography imaging protocol selection for morbidly obese patients High Priority, Efficiency and Cost/Resource Use
IGR7 SPECT-MPI or Stress Echocardiography imaging studies with adequate exercise testing performed  Not High Priority, Process
IGR8 SPECT-MPI or Stress Echocardiography study utilization of exercise as a stressor  Not High Priority, Process
 IGR9 Stress echo performance for shortness of breath per ASE guidelines High Priority, Efficiency and Cost/Resource Use
IGR10 Transthoracic Echo (TTE) performance per ASE guidelines High Priority, Efficiency and Cost/Resource Use

View Complete List of 2019 QCDR Measures.

View Complete List of 2018 QCDR Measures.